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EDITORIALS
“Shocking” the System to Achieve Efficient Gene Targeting in Primary
Human Airway Epithelia
The ability to knock out specific genes to gain an understanding of
their function is a mainstay of modern research, and the use of
technologies to achieve this goal to study pulmonary biology is no
exception. Homologous recombination in embryonic stem cells,
antisense oligonucleotides, sh/siRNA, and CRISPR-mediated
deletions are widely known and used. Most of these methods will
perform well in various model systems and cell lines, with the classic
method, homologous recombination in embryonic stem cells, being
highly useful in animals. However, for translational questions,
interspecies and/or cell line differences often require confirmation of
functional findings in primary human cells. Primary human airway
cultures are a highly valued model to study pulmonary biology, and
the application of robust gene knockdown technologies to these
cells is a valuable method to foster our knowledge in this field.
Unfortunately, as with other primary cell models, primary airway cells
generally remain persistently defiant to easy genetic manipulation.
Many examples of successful gene manipulation in human
airway cells can be found, including from our own laboratories.
However, in practice, although a method might work well for one
gene in one set of studies, it is not necessarily an indication that it
will be applicable for a different gene in separate experiments.
Furthermore, a method that seems to work efficiently with cells from
one human donor might suddenly not work effectively when
attempted in cells from another donor. This is true for all types of
technologies, including the use of 1) viral vectors (lentivirus,
adenovirus, and/or retroviral) to express knockdown components,
such as sh/siRNAs, CRISPR, and/or anti-sense species; 2) standard
lipofection methods; and 3) electroporation. An easy-to-use,
robust, economical, versatile, and efficient method to knock down
genes in primary human airway cells would represent an important
advance in the field.
As a step forward, the article by Koh and colleagues (pp. 373–
381) in this issue of the Journal (1) describes the optimization of a
method for targeting genes in primary human bronchial epithelial
cells (HBECs). They used electroporation of the necessary components
for CRISPR-mediated deletion (guide RNA [gRNA] sequences and
recombinant Cas9 complexes) in HBECs, which was nicely
demonstrated using a well-described model of the regulation of
MUC5AC (mucin 5AC) by SPEDF (SAM Pointed Domain
Containing ETS Transcription Factor) (2, 3). Knockdown of SPEDF is
predicted from the literature to dramatically reduce the upregulation
of MUC5AC expression resulting from treatment of HBECs with
IL-13, a central mediator of allergic asthma. Applying a variety of
experimental conditions, the authors were able to demonstrate near-
complete loss of SPEDF in HBEC cultures using their electroporation
method. Targeting of SPDEF with this technology was accompanied
by the expected loss of IL-13–mediated 1) upregulation of MUC5AC
and downregulation of MUC5B expression, 2) induction of goblet cell
differentiation, and 3) impairment of mucociliary clearance.
Although the science was mostly confirmatory of previous
studies regarding SPDEF-dependent function, the optimized
method provides a useful paradigm for other laboratories to follow.
Although the usual caveats with CRISPRs apply (e.g., gRNAs do not
always work as predicted), Koh and colleagues were able to demonstrate
that gRNAs shown to be efficient in relevant cell line models are
also effective in HBECs after electroporation of the CRISPR/gRNA
complexes (1). Prescreening of gRNA sequences is still recommended.
Once a gRNA is identified, it is synthesized and simply mixed with the
recombinant Cas9 to form a complex in the buffer recommended for
electroporation. Varying the timing of the electroporation and the
concentrations of the components altered the efficiency in predictable
ways, suggesting that the degree of gene knockdown could be
manipulated to the experimenter’s advantage. Hence, the method
might be also useful for studies evaluating the relationship between
the degree of gene expression and functional responses.
Importantly, a similar method has also recently been described
by Rapiteanu and colleagues (4), indicating that this approach can be
robust across laboratories; indeed, we are finding similar usefulness
of the technique in our own laboratories. Nevertheless, the target
gene still seems to matter, and success may remain out of reach for
difficult-to-target genes whose functions are necessary to maintain
the integrity of the HBECs as they differentiate in culture. The
technique still has some disadvantages, including cost, and time
will tell if it becomes a standard method for studying airway
pathophysiology. Nonetheless, the method optimized by Koh and
colleagues (1) significantly contributes to the growing arsenal of new
technologies that will drive the pulmonary biology field forward. n
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